E-brochure Newcastle - 2022 all countries - Catalog - Page 7
About Newcastle upon Tyne Hospitals
NHS
Foundation Trust (Newcastle Hospitals)
The Newcastle upon Tyne Hospitals NHS Foundation Trust (Newcastle Hospitals) is
one of the most successful NHS teaching Trusts in the country!
Newcastle Hospitals is one of the busiest, largest and most successful teaching Trusts in the country,
with around 16,000 staff and an annual income of £1billion.
Rated ‘Outstanding’ by the Care Quality Commission (CQC) for the second consecutive time in 2019,
Newcastle Hospitals have a long history of providing high quality care, clinical excellence, and
innovation in medical research regionally, nationally and internationally.
They are also the second largest provider of specialised services in the country supporting people with
a range of rare and complex medical, surgical and neurological conditions, cancers and genetic orders.
‘Outstanding’ service profile
Newcastle Hospitals staff oversee around 1.84m patient ‘contacts’ each year, delivering high standards
of healthcare from the following sites:
•
•
•
•
•
•
•
•
Freeman Hospital
Royal Victoria Infirmary (RVI)
Campus for Ageing and Vitality (the former Newcastle General Hospital site)
Newcastle Dental Hospital
Newcastle Fertility Centre
Northern Centre for Cancer Care, North Cumbria
Northern Genetics Service
Cramlington Manor Walks
These include a range of flagship services which deliver cutting-edge care (supported by state-of-theart diagnostic services in both radiology and pathology) and are a catalyst for innovation to support
pioneering clinical practice in the NHS.
Pioneering treatments
The Trust is at the forefront of pioneering treatments such as transplantation, mitochondrial donation
at the Newcastle Fertility Centre – a form of IVF in which the future baby’s mitochondrial DNA comes
from a donor egg to avoid passing on inherited diseases – and PrEP (Pre-exposure prophylaxis, a drug
to prevent HIV).
Furthermore, Newcastle Hospitals patients, both children and adults, will be amongst the first in the
world to receive CAR-T cell therapy which marks a new era of personalised medicine for treating
lymphoma and leukaemia.
Page 7
